Atlas Air Worldwide Appoints Debora Coffey Vice President and Chief Communications Officer
PURCHASE, N.Y., Dec. 03, 2018 (GLOBE NEWSWIRE) — Atlas Air Worldwide (Nasdaq: AAWW) announced today that Debora Coffey has been […]
ELBIT IMAGING ANNOUNCES UPDATED FINDINGS FROM GAMIDA CELL'S PHASE I/II STUDY OF NICORD
Tel Aviv, Israel, Dec. 03, 2018 (GLOBE NEWSWIRE) — Elbit Imaging Ltd. (TASE, NASDAQ: EMITF) (“Elbit”) announced today, further to […]
STMicroelectronics' Advanced Image Sensors Enhance Driver Monitoring in Next-Generation Automotive Safety Systems
Advanced image sensors enhance driver and passenger monitoring for safety and comfort Automotive electronic global shutter technology ideally suited […]
Boulanger Digitalizes Across its Procure-to-Pay Process on the Determine Cloud Platform
CARMEL, Ind. , Dec. 03, 2018 (GLOBE NEWSWIRE) — Determine, Inc. (NASDAQ: DTRM), a pioneering leader in global Source-to-Pay and […]
eXp World Holdings Appoints Dan Cahir to Its Board of Directors
BELLINGHAM, Wash., Dec. 03, 2018 (GLOBE NEWSWIRE) — eXp World Holdings, the holding company for eXp Realty, the largest residential […]
Luther Burbank Corporation Announces CEO Succession Plan
SANTA ROSA, Calif., Dec. 03, 2018 (GLOBE NEWSWIRE) — Luther Burbank Corporation (the “Company”) today announced that, effective January 2, […]
Potbelly Corporation Appoints New Chief Financial Officer and Announces Promotion in Operational Leadership
CHICAGO, Dec. 03, 2018 (GLOBE NEWSWIRE) — Potbelly Corporation (NASDAQ: PBPB) today announced that Thomas J. Fitzgerald will be joining […]
TOP Ships Inc. Announces Conclusion of Suezmax Financing and Additional Sources of Capital
ATHENS, Greece, Dec. 03, 2018 (GLOBE NEWSWIRE) — TOP Ships Inc. (the “Company”), an international owner and operator of modern, […]
Eyenovia Completes Patient Enrollment in MicroStat MIST-1 Study and Enrolls First Patient in MIST-2 Study
Topline results for the Phase III MicroStat Program for pharmacologic mydriasis expected H1 2019 NEW YORK, Dec. 03, 2018 (GLOBE […]
Zogenix Announces Positive Phase 3 Trial Results on the Efficacy and Safety of FINTEPLA® (ZX008) in Dravet Syndrome
Positive Data from Second Pivotal Phase 3 Trial (Study 1504) Consistent with Results of First Phase 3 Trial in Showing […]
